| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700056 | 重组全人源抗TNF-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-06-30 | 康宁杰瑞（吉林）生物科技有限公司 | Alphamab Jilin Co Ltd | Certificate Issued | 2018-10-29 | view |